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Abstract 
Objective: Low‑value health care refers to interventions where the risk of harm or costs exceeds the likely benefit for 
a patient. We aimed to develop indicators of low‑value care, based on selected Choosing Wisely (CW) recommenda‑
tions, applicable to routinely collected, hospital claims data.
Results: We assessed 824 recommendations from the United States, Canada, Australia and the United Kingdom CW 
lists regarding their capacity to be measured in administrative hospital admissions datasets. We selected recommen‑
dations if they met the following criteria: the service occurred in the hospital setting (observable in setting); a claim 
recorded the use of the service (record of service); the appropriate/inappropriate use of the service could be mapped 
to information within the hospital claim (indication); and the service is consistently recorded in the claims (consistent 
documentation). We identified 17 recommendations (15 services) as measurable. We then developed low‑value care 
indicators for two hospital datasets based on the selected recommendations, previously published indicators, and 
clinical input.
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Inappropriate care, Low‑value care, Quality 
measurement, Choosing Wisely, Hospitals, Quality of 
health care, Disinvestment
Introduction
Low-value care offers limited or no benefit and poses 
unnecessary risks and costs to patients [1, 2]. Publishing 
“do-not-do” recommendations, which detail inappro-
priate services for patient groups, is a recent strategy to 
redress low-value care. An example of this is the interna-
tional Choosing Wisely (CW) campaign [3].
One way to assess low-value care is to develop direct 
measures in routinely collected data [4]. These datasets, 
including health insurance claims and hospital adminis-
trative databases, provide population-level insights on 
service utilisation. Direct measures of low-value care 
use information collected at the individual patient level 
to distinguish inappropriate from appropriate care [5]. 
This approach contrasts with measuring low-value care 
indirectly via geographic variation in services, which 
does not necessarily distinguish unwarranted from war-
ranted variation. Using these direct measures is an addi-
tive approach to measuring low-value care, as described 
by Miller et al. [6], and is suitable for both patient- and 
service-centric measures of low-value care [7].
We isolated CW recommendations with characteristics 
conducive to indicator development, thus allowing for 
direct measurement in routinely collected data on inpa-
tient admissions. While these indicators are not formal 
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quality metrics, which would require further investiga-
tion of their reliability and validity, they can provide an 





Our two datasets were (1) hospital and medical claims 
from a group of Australian private health insurance 
(PHI) funds, and (2) public hospital admissions data 
from Australia’s most populous state (New South 
Wales). Australians can receive care in public or private 
hospitals, and care is funded by some combination of 
patients’ out-of-pocket payments, their PHI, and the 
government [8]. Both datasets include information on 
inpatient admissions, with details such as the patient’s 
age, gender, procedures during the admission, and 
diagnoses coded at discharge. The datasets cover differ-
ent populations (although not mutually exclusive), and 
are therefore not directly comparable.
The PHI dataset contains medical and hospital claims 
made to 13 Australian insurance funds, as well as the 
Hospital Casemix Protocol data, sent from hospitals 
to these insurance funds after a patient’s discharge 
and used by the Australian government and insurance 
industry [9]. Clinical coders record medical services 
using the Medicare Benefits Scheme (MBS) item num-
bers (if claimed by a clinician to the insurance fund) 
and the Australian Classification of Health Interven-
tions (ACHI). Within the public hospital dataset, this 
MBS code is not present since clinicians are not paid 
per service use. Both datasets have diagnosis infor-
mation coded using the International Classification 
of Diseases—10th revision—Australian Modification 
(ICD-10-AM).
Clinical information used in forming the diagnosis, 
such as results of pathology tests or imaging, is not 
available in either dataset. Prescribing information and 
pathology requests are also not included.
Criteria for whether a recommendation can be measured
We developed four criteria to consistently and trans-
parently select recommendations measurable in the 
two datasets used in our work. The specific criteria 
and their applied order exclude the least relevant (to 
the dataset) recommendations first, leaving those rec-
ommendations requiring further investigation and 
resources to determine their measurability.
i. Observable in setting The recommendation is rel-
evant to the dataset and its health care setting.
We excluded recommendations related to procedures 
or services unlikely to occur in an inpatient setting, 
such as those usually performed in general practice.
ii. Record of service in claim The service can be recorded 
in the claim as the relevant and specific code exists 
for it.
Australian inpatient claims include procedures but not 
the prescribing of medicines. Hence, recommendations 
related to in-hospital prescription drugs are not measur-
able in claims data.
iii. Indication It is possible to map the appropriate/inap-
propriate patient criteria for a service described in 
the recommendation to the information within the 
claim.
Sometimes the caveats on the recommended inap-
propriate use of a service are too non-specific compared 
with the clinical detail recorded in the claims. For exam-
ple, we cannot investigate a recommendation of the form 
“do not do … without careful consideration.” A CW Aus-
tralia recommendation states that inguinal hernia repair 
should not occur: “…without careful consideration, par-
ticularly in patients who have significant co-morbidities” 
[10]. A direct measure of low-value care based on this 
recommendation would arguably have poor specificity, 
because it would label too many appropriate inguinal 
hernia repairs as low-value.
iv. Consistent documentation The service is consistently 
recorded in the claim according to standard coding 
practices.
We cannot measure a recommendation across a pop-
ulation if the service is not consistently documented 
during the data collection, as the service count will be 
underreported. In some cases, a radiologist will claim 
for an imaging service for an admitted patient, so the 
relevant MBS item will be in the private claims dataset. 
However, the Australian Coding Standards for ACHI 
coding classify imaging services as ‘procedures not nor-
mally coded’, because “they are usually routine in nature, 
performed for most patients and/or can occur multiple 
times in an episode” [11]. Some low-value care described 
by these recommendations might be identifiable, and so 
these measures might be of interest to payers, but they 
are not generalisable because the estimates would be 
under-representative and possibly biased.
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Selecting measurable recommendations in hospital 
admissions data
We investigated 824 recommendations from CW lists in 
the US, Canada, Australia, and the UK, downloaded in 
January 2017 [12–15]. Two authors (KC, TBP) reviewed 
the recommendations independently to assess measura-
bility in the private and public datasets, and then resolved 
discrepancies by consensus. Figure  1 illustrates this 
review process according to the measurement criteria.
Adapting recommendations for measurement
We followed an approach used by Schwartz et  al. [16] 
and further described in Brett et  al. [17], and defined a 
narrow indicator (more specific, which might exclude 
some low-value care) and a broad indicator (more sen-
sitive, which might include some appropriate care) for 
each service when necessary. Where they exist, we used 
previously published indicators of these low-value ser-
vices as a starting point [16, 18] and adapted these based 
on the details in our data and health care setting, or 
modified them in response to clinical advice or updates 
to recommendations.
Even when a recommendation was measureable 
according to the criteria there could still be ambiguity 
on how to define low-value service use. For example, 
multiple recommendations relating to the same service 
were sometimes slightly different, such as two CW US 
recommendations on inferior vena caval filter use from 
the Society for Vascular Surgery and the American 
Society of Hematology.
For some indicators, we developed a proxy measure 
for the “asymptomatic” patient groups. We excluded 
patients with diagnoses related to possible symp-
toms (see definitions for carotid endarterectomy and 
endovascular repair of abdominal aortic aneurysms in 
Table 1).
When developing the narrow indicator we used the 
most restrictive of any duplicate or similar recom-
mendations, excluded procedures or diagnoses where 
appropriateness was unclear, and defined proxy meas-
ures to err towards counting care as appropriate. To 
Don't perform epidural steroid 
injecons to treat paents with low 
back pain who do not have radicular 
symptoms in the legs originang from 
the nerve roots  
Don't perform repair of minimally 
symptomac or asymptomac 
inguinal hernias without careful 
consideraon, parcularly in paents 
who have significant co-morbidies.  
Avoid prescribing anbiocs for 
upper respiratory tract infecon.  
Don't rounely do a pelvic 
examinaon with a Pap smear .  
Don't order chest x-rays in paents 
with uncomplicated acute bronchis .  
1. Observable in seng. 
Recommendaons on in-paent services
2. Record of service.  
Recommendaons where service can be 
coded in the claim
3. Indicaon.  
Recommendaons where inappropriate 
service use can be disnguished
4. Consistent documentaon. 
Recommendaons where service is 
rounely recorded in the claim 
EXAMPLE RECOMMENDATIONS 
EXCLUDED FROM MEASUREMENT 
EXAMPLE RECOMMENDATION 
INCLUDED IN MEASUREMENT 
Fig. 1 Criteria for direct measurement of Choosing Wisely recommendations, with example recommendations from Choosing Wisely Australia 
[10]. Recommendations are excluded in four stages, as described by the steps in the middle column. Four examples of excluded Choosing Wisely 
Australia recommendations are shown in the left column. Pap smear was excluded as this is a service usually provided in general practice. Antibiotic 
prescription was excluded as prescribing is not recorded within either the private or public available datasets. Inguinal hernia repair was excluded 
because the description of “minimally symptomatic or asymptomatic” or “careful consideration” is not recorded in the data. Finally, chest x‑rays 
were excluded as this is a service that is not usually coded in inpatient data, according to the Australian Coding Standards [11]. The example of the 
epidural steroid injection recommendation meets all four criteria for measurement
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develop the broader definition we included any ambig-
uous diagnosis or procedure codes that may capture 
inappropriate care, or adjusted the age, sex, or indica-
tions for which the service is potentially low-value.
Clinical review
Draft indicators were presented at a workshop involv-
ing 27 clinicians. Two authors (TBP and AGE) pre-
sented the overall approach, and invited feedback on 
the project as a whole. The clinicians then separated 
into groups where each reviewed 3 to 4 draft indica-
tors. The clinicians were asked to take the CW recom-
mendations as given (thus respecting the various CW 
processes for developing recommendations), and assess 
whether the narrow and broad indicators adequately 
captured the care targeted by the recommendation. 
They examined both the description of the indicator (as 
presented in Table 1) and the codes used in identifying 
low-value claims. We revised the indicators to incor-
porate the feedback, and a clinical coder reviewed the 
revised versions to assess the codes. Clinical co-authors 
(JB, IAS) resolved further questions about the indica-
tors, or we occasionally consulted other specialists, 
including those present at the workshop.
Results
We excluded 283 recommendations (34.3% of total) that 
were not observable in setting as they did not relate to 
inpatient services (Fig. 2). Then we excluded 203 (37.5%) 
of the remaining recommendations from measurement in 
the PHI data and 231 (42.7%) in the public hospital data, 
because there was no record of service in the datasets. 
These were mainly on pathology or prescribing services. 
The number excluded in the public and private hospi-
tal data differs because some services relate to an MBS 
item but not an ACHI code. For example, MBS items 
record inpatient intravitreal injections in PHI claims but 
not claims from public hospitals (and there is no specific 
ACHI code for this service).
Of the remaining recommendations, 93 (27.5%) met 
the indication criteria in the PHI data and 89 (28.7%) 
in the public hospital data, meaning we could identify 
a low-value indication for the service using the clinical 
details in the datasets.
Finally, we excluded 75 (81%) recommendations from 
the PHI data because the service was not consistently doc-
umented in the claims. We also excluded 72 (82%) from 
measurement in the public hospital data. This left 18 and 
17 measurable recommendations in the PHI and public 
hospital datasets respectively (2.06 and 1.94% of all rec-
ommendations). Throughout this selection process, we 
resolved discrepancies for 68 recommendations (8.25% 
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recommendation was relevant in an inpatient setting or if 
the low-value indication was measurable.
We adapted 17 of the 18 measurable recommenda-
tions into indicators. Three pairs of similar or identical 
recommendations were combined into single indicators 
(Table 1). We omitted a UK recommendation that most 
surgical procedures should be a day surgery and “vari-
ation in the use of day surgery for specific operations 
should be measured”. Although it is measurable, adapting 
this specific recommendation will require considerable 
input from practitioners for exclusion criteria, depend on 
regional health systems’ day surgery policies, and could 
include many procedures. We therefore developed 14 
indicators of low-value care.
During the clinical review process, participants sug-
gested diagnoses justifying the procedure, thus making 
the indicators more specifically targeted at low-value 
care. They also advised against a strict age limit for “lim-
ited life expectancy”, resulting in a proxy measure based 
on age and American Society of Anesthesiologists risk 
score.
Limitations
Eighteen of the 824 original recommendations were 
measurable in the datasets after excluding 807 (97.9%) 
recommendations. Similar studies have also found that 
most recommendations are not measurable in routinely 
collected data. Duckett et al. [18] identified 5 out of 1208 
(0.4%) low-value services they could measure in hospital 
data. In primary care data, Sprenger et al. [19] measured 
34 (2%) of 1658 recommendations. The small number of 
measurable recommendations is a consequence of the 
limited clinical information and health care setting cov-
erage of these datasets (e.g. non-linked inpatient, primary 
care, pathology, radiology and pharmaceutical data). 
Using linked data may mean more recommendations are 
measurable in routinely collected data.
824 recommendaons from Choosing Wisely US, 
Canada, Australia, UK 
1. Observable in seng. 





283 (34.34%) excluded 283 (34.34 %) excluded 
541 recommendaons 
2. Record of service. Recommendaons 
where service can be coded in the claim 
203 (37.52%) excluded 231 (42.70%) excluded 
3. Indicaon. Recommendaons where 
inappropriate service use can be 
disnguished 
245 (72.49%) excluded 221 (71.29%) excluded 
4. Consistent documentaon. 
Recommendaons where service is 
rounely recorded in the claim  
75 (80.65%) excluded 72 (80. 90%) excluded 
18 (2.18%) recommendaons 17 (2.06%) recommendaons 
338 recommendaons 310 recommendaons 
93 recommendaons 89 recommendaons 
Fig. 2 Recommendations excluded at each step, for public and private datasets. Recommendations were downloaded from the websites of 
the Choosing Wisely initiatives in the United States, Canada, Australia, and the United Kingdom in January 2017 [12–15]. All recommendations 
were then assessed against the four criteria in the Australian hospital inpatient setting and the private and public inpatient claims data settings. 
Differences in the measurable recommendations between private and public are due to differences in the variables held in the two datasets
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Our operational definitions of low-value care would 
benefit from further validation, such as comparison to 
a clinical chart review. This is a common issue when 
measuring low-value care in routinely collected data 
[20]. Validation studies using clinical chart review have, 
however, suggested either reasonable agreement or a 
conservative estimate of low-value care using the rou-
tine data approach [21–23].
These indicators are useful for examining variation 
and trends and to prioritise low-value care initiatives. 
CW is clinician-led and aims to facilitate discussions 
on appropriate care between doctors and patients, and 
not to proscribe services [24, 25]. Large questions still 
exist around the utility of auditing and feeding back 
low-value care measurement data to hospital managers 
and clinicians, recognising there is potential risk to the 
goodwill underlying Choosing Wisely type initiatives 
[24]. These indicators are useful, however, in facilitat-
ing questions and discussions regarding the true extent 
of low-value care, particularly where rates appear high 
within particular settings.
Our criteria allow systematic and transparent selec-
tion of recommendations for direct measurement 
within our data setting. The criteria and approach can 
be replicated in other data settings, including out-
side Australia, as well as other inappropriate care 
recommendations.
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